Richard A. Larson to Ikaros Transcription Factor
This is a "connection" page, showing publications Richard A. Larson has written about Ikaros Transcription Factor.
Connection Strength
0.131
-
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016 10; 57(10):2298-306.
Score: 0.131